Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. operates a digital healthcare platform focused on prescription and medication savings in the United States. Company news commonly covers prescription transaction revenue, retail pharmacy trends, negotiated discount pricing, PBM relationships, and the expansion of Pharma Direct manufacturer programs that connect branded drug discounts to consumers at the pharmacy counter.
GoodRx updates also include self-pay pricing arrangements for GLP-1 and other branded medications, subscription health services such as condition-specific programs, earnings releases, business outlook commentary, and partnerships with pharmaceutical manufacturers, pharmacies, payers, and healthcare professionals.
GoodRx Holdings (Nasdaq: GDRX) plans to release its Q2 2021 financial results on August 12, 2021, before U.S. markets open. A conference call will follow at 5:00 a.m. PT (8:00 a.m. ET) to discuss the results and business outlook. A shareholder letter and detailed financial results will be available on their investor relations website. GoodRx is recognized as America's leading resource for healthcare savings, having helped Americans save over $30 billion since 2011 and is the most downloaded medical app for the last three years.
GoodRx (NASDAQ: GDRX) has partnered with DoorDash (NYSE: DASH) to offer discounted access to its GoodRx Gold subscription program for DoorDash drivers, known as 'Dashers.' This partnership allows Dashers to save up to 90% on over 1,000 medications and provides online doctor visit discounts along with free mail delivery for prescriptions. GoodRx Gold can save individuals an average of $2,600 annually when filling 2 prescriptions monthly. This initiative aims to enhance healthcare access for the growing freelance workforce in the U.S., which comprises 35% of all workers.
GoodRx (NASDAQ: GDRX) released a report detailing its positive impact on American healthcare, showcasing significant savings for patients. In 2020, GoodRx users saved an average of 79% on medications, equating to around $30 billion in total savings. The platform has improved medication adherence, contributing to the prevention of over 1,000 hospitalizations and saving nearly 500 lives. Additionally, over 20% of Americans reported struggling with basic necessities due to medication costs, highlighting the importance of GoodRx in alleviating financial burdens.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its financial results for the first quarter of 2021, showcasing its role as a leader in healthcare savings in the U.S. The company has facilitated over $30 billion in savings since 2011. A conference call to discuss these results and the business outlook is scheduled for May 13, 2021, at 2:00 PM PT. GoodRx emphasizes its services, including affordable prescriptions, telehealth, and lab tests, making it the #1 most downloaded medical app for the last three years.
GoodRx Holdings (Nasdaq: GDRX), a leader in healthcare savings, announced upcoming presentations at two virtual investor conferences. The RBC Capital Markets Global Healthcare Conference will take place on May 19 at 1:15 p.m. PT, followed by the Evercore ISI TMT Conference on June 7 at 9:30 a.m. PT. Live webcasts and archived recordings of these presentations can be accessed via GoodRx's Investor Relations website. GoodRx has saved Americans over $25 billion since 2011 and remains the most downloaded medical app for three consecutive years.
GoodRx (Nasdaq: GDRX) has launched an integrated offering with Sanofi to simplify access to manufacturer discounts for insulin and other prescriptions. This collaboration aims to assist uninsured and commercially insured diabetes patients, potentially saving Americans up to $260 million in 2021. Patients can now find and claim Sanofi discounts directly on the GoodRx platform. Currently, insured patients can pay between $0 to $10 for select drugs, while uninsured patients face a flat fee of $99 monthly for specific insulins. This initiative is expected to enhance affordability for millions of diabetes patients.
GoodRx (NASDAQ: GDRX) has completed the acquisition of HealthiNation, enhancing its healthcare resources. With a vast library of premium health videos, HealthiNation enables GoodRx to deliver superior content and information to consumers while offering manufacturers targeted engagement opportunities. This move aligns with GoodRx’s strategy to bolster its Manufacturing Solutions business and improve health outcomes for users. The acquisition highlights GoodRx's commitment to affordable healthcare solutions, leveraging HealthiNation's expertise for greater market reach.
GoodRx Holdings Inc. (GDRX) announced its first quarter 2021 financial results will be released after U.S. markets close on May 13, 2021. A conference call will follow at 2:00 p.m. PT to discuss the results and future outlook. GoodRx has helped Americans save over $25 billion since 2011, becoming the top downloaded medical app for the past three years. The press release will also include a link to a shareholder letter and results on its investor relations site.
GoodRx (GDRX) has launched a Vaccine Guide to assist users in navigating the rollout of the COVID-19 vaccine. Collaborating with the CDC and VaccineFinder, GoodRx tracks vaccine availability at over 50,000 locations, including pharmacies and clinics. The guide allows consumers to find vaccination appointments and the types of vaccines available. Notably, more than 1.8 million Americans have subscribed for text alerts on local eligibility and updates. GoodRx has saved Americans over $25 billion in healthcare costs since 2011, becoming the #1 downloaded medical app in the last three years.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its fourth quarter and full year 2020 financial results, emphasizing its role as a leading healthcare savings resource. The company has facilitated over $25 billion in savings for Americans since 2011. Investors can access the full results and a shareholder letter on the company's investor relations website. A conference call is scheduled for March 11, 2021, at 2:00 p.m. PT to discuss these results further.